Physician Experiences With and Perspectives on Clozapine Prescribing
In this survey study of physician prescribers of clozapine, a majority were satisfied with the clozapine REMS program but highlighted the need for enhanced educational materials and administrative efficiency.
Authors
- Ameet Sarpatwari (ORCID: https://orcid.org/0000-0001-5043-6206)
- Gita A. Toyserkani (ORCID: https://orcid.org/0000-0002-6946-6138)
- Heidi Zakoul (ORCID: https://orcid.org/0009-0008-3022-9013)
- Esther H. Zhou (ORCID: https://orcid.org/0000-0003-4608-6850)
- Cynthia LaCivita (ORCID: https://orcid.org/0009-0001-8680-9008)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Su Been Lee (ORCID: https://orcid.org/0000-0002-3437-097X)
- Gerald J. Dal Pan (ORCID: https://orcid.org/0000-0003-4874-5864)
- Massimiliano Russo (ORCID: https://orcid.org/0000-0003-4953-9341)
- Zhigang Lu
- Katherine Hyatt Hawkins Shaw
Institutions
- Brigham and Women's Hospital (US)
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
- Harvard University (US)
- The Ohio State University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.59311
- Citations
- 2
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Brigham and Women's Hospital